Zobrazeno 1 - 10
of 1 117
pro vyhledávání: '"iron chelation therapy"'
Autor:
Sally MacVinish, Crystal van Leeuwen, Maartje Hoetjes, Yoshihiro Aoki, Deirdre Foley, Harriet Roggeveen
Publikováno v:
Conflict and Health, Vol 17, Iss 1, Pp 1-10 (2023)
Abstract Background Thalassaemia affects many families in Northeast Syria, an area devastated by over a decade of conflict which has significantly impacted their health system. People with thalassaemia require holistic multidisciplinary care for the
Externí odkaz:
https://doaj.org/article/46b022e8e70e481f8881d56897b3f88f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 326-342 (2022)
Introduction Iron chelation therapy (ICT) is essential to prevent complications of iron overload in patients with transfusion-dependent thalassaemia. However, there is currently no standard for how to best measure adherence to ICT, nor what level of
Externí odkaz:
https://doaj.org/article/d443f16832a64cf8b2b05d68b1675bf5
Autor:
Shruti Kakkar, Vaneet Anand, Rashmi Kapoor, Sukhmani Sidhu, Amanat Grewal, Mehak Chawla, J.S. Goraya
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 7, Iss 3, Pp 77-80 (2022)
Introduction: COVID-19 pandemic imposed challenges towards management of transfusion-dependent thalassemia patients (TDT). The need for regular blood transfusions and iron chelation therapy in these patients added further uncertainty about managing C
Externí odkaz:
https://doaj.org/article/5f4ebda9b5504f4e8e6d199c7146dbb1
Autor:
George J. Kontoghiorghes
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 23, p 16749 (2023)
The design of clinical protocols and the selection of drugs with appropriate posology are critical parameters for therapeutic outcomes. Optimal therapeutic protocols could ideally be designed in all diseases including for millions of patients affecte
Externí odkaz:
https://doaj.org/article/f5607d2f999b4bd8b3d131e9222d3ada
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Patient Preference and Adherence, Vol Volume 16, Pp 1423-1437 (2022)
Chinea Eziefula,1,2 Farrukh T Shah,3,4 Kofi A Anie5,6 1Camden & Islington NHS Foundation Trust, London, UK; 2Psychology Services, Whittington Health NHS Trust, London, UK; 3Department of Haematology, Whittington Health NHS Trust, London, UK; 4Medical
Externí odkaz:
https://doaj.org/article/e1eb71a466594510a2a472be7d9ff8d5
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 7, Iss 3, Pp 74-76 (2022)
Introduction: COVID-19 pandemic imposed challenges towards management of transfusion-dependent thalassemia patients (TDT). The need for regular blood transfusions and iron chelation therapy in these patients added further uncertainty about managing C
Externí odkaz:
https://doaj.org/article/d133cbbc70884ed7a5f289afc1837989
Publikováno v:
Journal of Blood Medicine, Vol Volume 12, Pp 1019-1030 (2021)
Sarah Parisi,1 Carlo Finelli2 1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy; 2IRCCS Azienda Osp
Externí odkaz:
https://doaj.org/article/13fa4193da1b4fd292ba8f964c3b6833
Autor:
Allen Shiun Chat Chai, Nani Draman, Siti Suhaila Mohd Yusoff, Nurul Fatihah Azman, Maryam Mohd Zulkifli, Najib Majdi Yaacob, Norsarwany Mohamad, Rosline Hassan, Wan Zaidah Abdullah, Bin Alwi Zilfalil
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 6, Iss 4, Pp 207-215 (2021)
Aim: To determine the proportion of non-compliance to iron chelation therapy (ICT) and its associated factors amongst patients with transfusion-dependent thalassaemia (TDT) in Malaysia. Methods: A cross-sectional study was conducted amongst patients
Externí odkaz:
https://doaj.org/article/bb2fb85b09004af29ed2798b9293fd31